Susvimo (Ranibizumab Injection) 100 mg/mL

Susvimo (Ranibizumab) 100 mg/mL injection is a prescription eye treatment used to manage retinal conditions. This formulation supports sustained delivery for targeted therapy. Ideal for patients seeking advanced ocular care solutions.

Strength

100 mg/mL

Manufacturer / TM Owner

GENENTECH PHYS DISOUNT/NON LUCENTIS

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Susvimo (Ranibizumab) 100 mg/mL injection is primarily used to treat retinal diseases such as wet age-related macular degeneration (AMD) and diabetic macular edema (DME). It helps reduce abnormal blood vessel growth in the retina, supporting vision maintenance. Patients with retinal swelling or leakage may benefit from this therapy.

Side Effects

After administration, Susvimo (Ranibizumab) works by targeting specific proteins to slow the progression of retinal damage. Many patients notice improved clarity or stability in vision over time. The injection is designed for long-term management of chronic eye conditions.

Precautions & Warnings

Store Susvimo (Ranibizumab) 100 mg/mL injection in a cool, dry place away from direct light. Keep out of reach of children and pets. Handle with care to avoid contamination or damage to the vial. Always follow healthcare provider instructions for safe use.

Avoid Interactions

Susvimo (Ranibizumab) may interact with other medications affecting blood vessels or immune responses. Inform your doctor about all prescriptions, over-the-counter drugs, or supplements you use. Avoid combining with blood thinners unless directed by a healthcare professional.

References

Frequently Asked Questions

Susvimo is used for retinal diseases like wet age-related macular degeneration and diabetic macular edema.

It is given as an injection directly into the eye by a healthcare provider.

No, Susvimo is specifically for wet AMD and other conditions involving abnormal blood vessel growth.

Common effects may include redness, discomfort, or temporary vision changes after injection.

No, Susvimo requires a prescription and must be administered by a medical professional.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.